Published in Exp Neurobiol on December 31, 2010
The Parkinsonian mimetic, 6-OHDA, impairs axonal transport in dopaminergic axons. Mol Neurodegener (2014) 0.85
Changes in functional organization and white matter integrity in the connectome in Parkinson's disease. Neuroimage Clin (2016) 0.75
The effects of gestational and chronic atrazine exposure on motor behaviors and striatal dopamine in male Sprague-Dawley rats. Toxicol Appl Pharmacol (2015) 0.75
Parkinson's disease: mechanisms and models. Neuron (2003) 14.84
PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol (2010) 11.85
Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci (2007) 7.96
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci (1973) 7.85
Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res (2004) 7.06
The familial Parkinsonism gene LRRK2 regulates neurite process morphology. Neuron (2006) 4.51
Axonal self-destruction and neurodegeneration. Science (2002) 4.30
Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat Neurosci (2001) 4.10
Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease. Nat Neurosci (2009) 3.24
Axonal mitochondrial transport and potential are correlated. J Cell Sci (2004) 3.15
Parkinson's disease. Lancet (2004) 3.08
Axonal transport defects in neurodegenerative diseases. J Neurosci (2009) 2.74
Pink1 forms a multiprotein complex with Miro and Milton, linking Pink1 function to mitochondrial trafficking. Biochemistry (2009) 2.38
Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide. J Neurosci (2009) 2.15
Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease. Brain (2007) 2.10
Nicotinamide mononucleotide adenylyltransferase expression in mitochondrial matrix delays Wallerian degeneration. J Neurosci (2009) 1.78
Nmnat delays axonal degeneration caused by mitochondrial and oxidative stress. J Neurosci (2008) 1.54
Mitochondrial transport and docking in axons. Exp Neurol (2009) 1.41
Selective vulnerability of dopaminergic neurons to microtubule depolymerization. J Biol Chem (2005) 1.38
Parkinson's disease alpha-synuclein mutations exhibit defective axonal transport in cultured neurons. J Cell Sci (2004) 1.36
Non-apoptotic neurite degeneration in apoptotic neuronal death: pivotal role of mitochondrial function in neurites. Neuroscience (2003) 1.34
The parkinsonism producing neurotoxin MPP+ affects microtubule dynamics by acting as a destabilising factor. FEBS Lett (2005) 1.16
Wld(S) mice are protected against the Parkinsonian mimetic MPTP. Exp Neurol (2006) 1.13
Axonal degeneration and regeneration: a mechanistic tug-of-war. J Neurochem (2008) 1.10
Mitochondrial dynamics, cell death and the pathogenesis of Parkinson's disease. Apoptosis (2010) 1.10
Recent clinical failures in Parkinson's disease with apoptosis inhibitors underline the need for a paradigm shift in drug discovery for neurodegenerative diseases. Biochem Pharmacol (2006) 1.09
Perspectives on recent advances in the understanding and treatment of Parkinson's disease. Eur J Neurol (2009) 0.95
Parkinson's disease: Exit toxins, enter genetics. Prog Neurobiol (2009) 0.95
Mitochondrial dynamics and neurodegeneration. Curr Neurol Neurosci Rep (2009) 0.93
Dynamic transport and localization of alpha-synuclein in primary hippocampal neurons. Mol Neurodegener (2010) 0.89